松本准教授の論文がLeukemia Resに採択されました。

Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase

Jun Matsumoto, Tatsuaki Takeda, Shiho Sugimoto, Tomonori Sakai, Beatrix Bermudo Loyao, Tsukasa Higashionna, Hirofumi Hamano, Gerard Lee Lo See, Noritaka Ariyoshi, and Yoshito Zamami